[go: up one dir, main page]

PT828733E - Benzopiranos e composicoes farmaceuticas que os contem - Google Patents

Benzopiranos e composicoes farmaceuticas que os contem Download PDF

Info

Publication number
PT828733E
PT828733E PT96917431T PT96917431T PT828733E PT 828733 E PT828733 E PT 828733E PT 96917431 T PT96917431 T PT 96917431T PT 96917431 T PT96917431 T PT 96917431T PT 828733 E PT828733 E PT 828733E
Authority
PT
Portugal
Prior art keywords
benzopyran
dihydro
dimethyl
hydroxy
oxo
Prior art date
Application number
PT96917431T
Other languages
English (en)
Portuguese (pt)
Inventor
Paul W Manley
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10774940&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT828733(E) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PT828733E publication Critical patent/PT828733E/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/70—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with two hydrocarbon radicals attached in position 2 and elements other than carbon and hydrogen in position 6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
PT96917431T 1995-05-24 1996-05-24 Benzopiranos e composicoes farmaceuticas que os contem PT828733E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9510477.4A GB9510477D0 (en) 1995-05-24 1995-05-24 Organic compounds

Publications (1)

Publication Number Publication Date
PT828733E true PT828733E (pt) 2002-02-28

Family

ID=10774940

Family Applications (1)

Application Number Title Priority Date Filing Date
PT96917431T PT828733E (pt) 1995-05-24 1996-05-24 Benzopiranos e composicoes farmaceuticas que os contem

Country Status (30)

Country Link
US (1) US5905156A (fr)
EP (1) EP0828733B1 (fr)
JP (1) JPH11505820A (fr)
KR (1) KR100437981B1 (fr)
CN (1) CN1077888C (fr)
AR (1) AR004489A1 (fr)
AT (1) ATE205204T1 (fr)
AU (1) AU703276B2 (fr)
BR (1) BR9609048A (fr)
CA (1) CA2217821C (fr)
CO (1) CO4700520A1 (fr)
CZ (1) CZ294474B6 (fr)
DE (1) DE69615019T2 (fr)
DK (1) DK0828733T3 (fr)
ES (1) ES2163634T3 (fr)
FI (1) FI973992L (fr)
GB (1) GB9510477D0 (fr)
HU (1) HU222772B1 (fr)
IL (1) IL118382A (fr)
MY (1) MY114924A (fr)
NO (1) NO314846B1 (fr)
NZ (1) NZ309765A (fr)
PL (1) PL184144B1 (fr)
PT (1) PT828733E (fr)
RU (1) RU2160735C2 (fr)
SK (1) SK283215B6 (fr)
TR (1) TR199701417T1 (fr)
TW (1) TW421646B (fr)
WO (1) WO1996037490A1 (fr)
ZA (1) ZA964209B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5972894A (en) * 1997-08-07 1999-10-26 Cytran, Inc. Peptides having potassium channel opener activity
GB9822024D0 (en) * 1998-10-09 1998-12-02 Novartis Ag Organic compounds
GB9909792D0 (en) 1998-12-04 1999-06-23 Cambridge Bioclinical Limited Potassium channel activators and their use
US6384244B2 (en) 2000-05-18 2002-05-07 Merck & Co., Inc. Process for preparing cis- aminochromanols
CA2496847C (fr) * 2002-08-29 2011-06-07 Nissan Chemical Industries, Ltd. Procede permettant de produire un compose aminobenzopyrane
US7098340B2 (en) * 2003-05-14 2006-08-29 Warner Lambert Company Llc Benzyl sulfonamide derivatives
KR100704009B1 (ko) * 2005-08-30 2007-04-04 한국화학연구원 염증억제 활성을 가지는6-알킬아미노-2-메틸-2'-(ｎ-메틸치환술폰아미도)메틸-2ｈ-1-벤조피란 유도체
JP6987746B2 (ja) 2015-09-28 2022-01-05 ジェネンテック， インコーポレイテッド 治療用化合物及びその使用方法
CN106008288A (zh) * 2016-06-15 2016-10-12 西北农林科技大学 一种苯磺酰胺类化合物及其用途
CN110546148A (zh) 2017-03-24 2019-12-06 基因泰克公司 作为钠通道抑制剂的4-哌啶-n-(嘧啶-4-基)色满-7-磺酰胺衍生物
TW202003490A (zh) 2018-05-22 2020-01-16 瑞士商赫孚孟拉羅股份公司 治療性化合物及其使用方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4971982A (en) * 1987-07-06 1990-11-20 Hoffmann-La Roche Inc. Benzopyran derivatives
ES2030627A6 (es) * 1990-11-28 1992-11-01 Uriach & Cia Sa J Procedimiento para la obtencion de compuestos benzopiranicos.
GB9102803D0 (en) * 1991-02-11 1991-03-27 Ici Plc Pyridine compounds
KR950009863B1 (ko) * 1991-05-22 1995-08-29 재단법인한국화학연구소 벤조피란 유도체와 그의 제조방법
TW244350B (fr) * 1991-12-14 1995-04-01 Hoechst Ag
US5236935A (en) * 1992-05-21 1993-08-17 Korea Research Institute Of Chemical Technology Benzopyran derivatives and processes for the preparation thereof

Also Published As

Publication number Publication date
HU222772B1 (hu) 2003-10-28
KR19990021925A (ko) 1999-03-25
RU2160735C2 (ru) 2000-12-20
DE69615019T2 (de) 2002-06-06
PL324042A1 (en) 1998-05-11
JPH11505820A (ja) 1999-05-25
KR100437981B1 (ko) 2004-07-16
CZ294474B6 (cs) 2005-01-12
EP0828733B1 (fr) 2001-09-05
IL118382A (en) 2000-01-31
IL118382A0 (en) 1996-09-12
AU703276B2 (en) 1999-03-25
ZA964209B (en) 1997-11-24
NO975365L (no) 1998-01-15
FI973992A0 (fi) 1997-10-17
ATE205204T1 (de) 2001-09-15
FI973992A7 (fi) 1997-12-09
CN1077888C (zh) 2002-01-16
DE69615019D1 (de) 2001-10-11
CO4700520A1 (es) 1998-12-29
HUP9801751A3 (en) 1999-08-30
WO1996037490A1 (fr) 1996-11-28
NO314846B1 (no) 2003-06-02
MY114924A (en) 2003-02-28
CZ368897A3 (cs) 1998-02-18
TR199701417T1 (xx) 1998-02-21
AR004489A1 (es) 1998-12-16
SK157797A3 (en) 1998-05-06
AU6000896A (en) 1996-12-11
CA2217821C (fr) 2008-05-06
MX9709004A (es) 1998-03-31
TW421646B (en) 2001-02-11
DK0828733T3 (da) 2001-12-17
EP0828733A1 (fr) 1998-03-18
FI973992L (fi) 1997-12-09
CN1185153A (zh) 1998-06-17
PL184144B1 (pl) 2002-09-30
HK1014137A1 (en) 1999-09-24
US5905156A (en) 1999-05-18
BR9609048A (pt) 1999-02-23
CA2217821A1 (fr) 1996-11-28
SK283215B6 (sk) 2003-03-04
GB9510477D0 (en) 1995-07-19
HUP9801751A2 (hu) 1999-06-28
ES2163634T3 (es) 2002-02-01
NZ309765A (en) 2000-01-28
NO975365D0 (no) 1997-11-21

Similar Documents

Publication Publication Date Title
EP0885888B1 (fr) Derives de l'isoquinoline et medicaments associes
PT99775B (pt) Processo para a preparacao de novos derivados de di-hidroisoquinolina
US4980359A (en) Isoquinoline derivatives and their use
DK169337B1 (da) Xanthinforbindelser, farmaceutisk præparat indeholdende disse, xanthinforbindelser til anvendelse som et farmaceutisk middel samt fremgangsmåde til fremstilling af forbindelserne
PT828733E (pt) Benzopiranos e composicoes farmaceuticas que os contem
HU203234B (en) Process for producing new, multiply oxygenated labdane derivatives and pharmaceutical compositions comprising such compounds as active ingredient
JPH0730072B2 (ja) 置換３，４‐ジヒドロ‐２ｈ‐ベンゾピラン
US4818772A (en) Derivatives of 4-aminoethoxy-5-isopropyl-2-methylbenzenes: methods of synthesis and utilization as medicines
US5574049A (en) 2,2-dialkyl- and 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrans
WO1994012493A1 (fr) 2,2-dialkyl- et 2,2-dkalkyl-3,4-dihydro-3-hydroxy-2h-1-benzopyrannes et leur utilisation comme produits pharmaceutiques
MXPA97009004A (en) Benzopira
AU665040B2 (en) 4-carboxamido-6(pyridin-4-yl substituted benzopyran derivatives
RU2104277C1 (ru) 2-2-диалкил- или транс-2,2-диалкил-3,4-дигидро-3-гидрокси-6-(пиридин-4-ил)-2н-1-бензопиран
WO2000021957A1 (fr) Benzopyrannes possedant une activite d'ouverture des canaux a potassium
CN118993944A (zh) 胍基取代的芳香酯类衍生物、其制备方法及在医药上的应用
JP2583028B2 (ja) ２，２−ジアルキル−および２，２−ジアルキル−３，４−ジヒドロ−３−ヒドロキシ−−２ｈ−１−ベンゾピラン類
CZ282091B6 (cs) 2,2-Dialkyl-2H-1-benzopyrany a 2,2-dialkyl-3,4-dihydro-3-hydroxy-2H-1-benzopyrany
JP2011500764A (ja) フェニルピロリジン化合物
PL172371B1 (pl) Sposób wytwarzania 2,2-diaikilo- i 2,2-dialkilo-3,4- dihydro-3-hydroksy-2H-1-benzopiranów PL
HK1014137B (en) Benzopyrans and pharmaceutical compositions containing them
JPH04226977A (ja) ベンゾピラン誘導体およびその製造法